Total Payments
$33,928
2024 Payments
$84.32
Companies
6
Transactions
57
Medicare Patients
507
Medicare Billing
$48,738
Payment Breakdown by Category
Consulting$29,845 (88.0%)
Travel$2,967 (8.7%)
Food & Beverage$1,070 (3.2%)
Education$45.10 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $29,845 | 19 | 88.0% |
| Travel and Lodging | $2,967 | 13 | 8.7% |
| Food and Beverage | $1,070 | 24 | 3.2% |
| Education | $45.10 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $15,924 | 28 | $0 (2024) |
| Eisai Inc. | $9,537 | 14 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,365 | 12 | $0 (2021) |
| Harmony Biosciences LLC | $45.10 | 1 | $0 (2022) |
| Philips Electronics North America Corporation | $31.21 | 1 | $0 (2017) |
| Avadel CNS Pharmaceuticals, LLC | $25.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.32 | 2 | JAZZ PHARMACEUTICALS INC. ($59.05) |
| 2022 | $45.10 | 1 | Harmony Biosciences LLC ($45.10) |
| 2021 | $11,683 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($8,365) |
| 2020 | $39.10 | 1 | Jazz Pharmaceuticals Inc. ($39.10) |
| 2019 | $9,565 | 15 | Eisai Inc. ($9,537) |
| 2018 | $8,439 | 13 | Jazz Pharmaceuticals Inc. ($8,439) |
| 2017 | $4,072 | 10 | Jazz Pharmaceuticals Inc. ($4,041) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $59.05 | General |
| Category: NEUROLOGY | ||||||
| 05/08/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 05/16/2022 | Harmony Biosciences LLC | Wakix (Drug) | Education | Cash or cash equivalent | $45.10 | General |
| Category: Neurological Disorders | ||||||
| 12/15/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $880.00 | General |
| 07/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $626.75 | General |
| 05/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $626.75 | General |
| 04/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $408.75 | General |
| 04/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $408.75 | General |
| 04/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $708.00 | General |
| 04/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $681.00 | General |
| 04/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 02/01/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $2,420.00 | General |
| 01/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,907.50 | General |
| 01/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $817.50 | General |
| 01/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 01/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 01/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 03/04/2020 | Jazz Pharmaceuticals Inc. | XYREM (Drug) | Food and Beverage | In-kind items and services | $39.10 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2019 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | Cash or cash equivalent | $27.74 | General |
| 07/22/2019 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $3,240.00 | General |
| 02/24/2019 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $4,740.00 | General |
| 02/24/2019 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $457.61 | General |
| 02/24/2019 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $302.68 | General |
| 02/24/2019 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $268.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 119 | 135 | $61,648 | $12,289 |
| 2022 | 4 | 133 | 149 | $61,604 | $13,371 |
| 2021 | 6 | 153 | 169 | $63,598 | $14,336 |
| 2020 | 3 | 102 | 125 | $41,469 | $8,742 |
Total Patients
507
Total Services
578
Medicare Billing
$48,738
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 85 | $37,870 | $7,441 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 26 | $16,278 | $3,309 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $7,500 | $1,538 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 71 | $29,645 | $6,837 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 23 | $13,425 | $2,960 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 39 | $11,414 | $2,074 | 18.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 16 | 16 | $7,120 | $1,500 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 56 | $21,340 | $4,921 | 23.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 49 | $13,068 | $3,016 | 23.1% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 26 | 26 | $11,666 | $2,536 | 21.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $7,694 | $1,770 | 23.0% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 11 | 11 | $5,142 | $1,076 | 20.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $4,688 | $1,016 | 21.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 78 | $27,820 | $5,658 | 20.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 36 | $8,784 | $1,999 | 22.8% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2020 | 11 | 11 | $4,865 | $1,086 | 22.3% |
About David Rye, M.D., PH.D
David Rye, M.D., PH.D is a Neurology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952412710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Rye, M.D., PH.D has received a total of $33,928 in payments from pharmaceutical and medical device companies, with $84.32 received in 2024. These payments were reported across 57 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($29,845).
As a Medicare-enrolled provider, Rye has provided services to 507 Medicare beneficiaries, totaling 578 services with total Medicare billing of $48,738. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Atlanta, GA
- Active Since 08/31/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952412710
Products in Payments
- XYWAV (Drug) $76.96
- Xyrem (Drug) $75.73
- Wakix (Drug) $45.10
- XYREM (Drug) $39.10
- DreamStat Cpap Auto (Device) $31.21
- LUMRYZ (Drug) $25.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlanta
Dr. Joash Lazarus, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Robert Gilbert, M.d, M.D
Neurology — Payments: $946,678
Neurology $946,678
Douglas Stuart, M.d, M.D
Neurology — Payments: $807,499
Neurology $807,499
Frank Berenson, Md, MD
Neurology — Payments: $628,973
Neurology $628,973
Julio Flamini, M.d, M.D
Neurology — Payments: $554,096
Neurology $554,096
Lawrence Seiden, M.d, M.D
Neurology — Payments: $318,322
Neurology $318,322